This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Understanding the `added value' of new drugs. Pharmacoecon. Outcomes News 275, 6 (2000). https://doi.org/10.1007/BF03267322
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03267322